Cargando…
The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease
Prescription of mucoactive drugs for chronic obstructive pulmonary disease (COPD) is increasing. This development in clinical practice arises, at least in part, from a growing understanding of the important role that exacerbation frequency, systemic inflammation and oxidative stress play in the path...
Autores principales: | Hooper, C, Calvert, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650606/ https://www.ncbi.nlm.nih.gov/pubmed/19281081 |
Ejemplares similares
-
S-carboxymethylcysteine in the treatment of glue ear: quantitative systematic review
por: Moore, Robert Andrew, et al.
Publicado: (2001) -
Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis
por: Zeng, Zheng, et al.
Publicado: (2017) -
Carbocisteine inhibits the expression of Muc5b in COPD mouse model
por: Song, Yan, et al.
Publicado: (2019) -
Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
por: Dhanure, Shivanand, et al.
Publicado: (2014) -
L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report
por: Takaki, Yugo, et al.
Publicado: (2022)